Unknown

Dataset Information

Single cell and lineage tracing studies reveal the impact of CD34+ cells on myocardial fibrosis during heart failure.


ABSTRACT:

Background

CD34+ cells have been used to treat the patients with heart failure, but the outcome is variable. It is of great significance to scrutinize the fate and the mechanism of CD34+ cell differentiation in vivo during heart failure and explore its intervention strategy.

Methods

We performed single-cell RNA sequencing (scRNA-seq) of the total non-cardiomyocytes and enriched Cd34-tdTomato+ lineage cells in the murine (male Cd34-CreERT2; Rosa26-tdTomato mice) pressure overload model (transverse aortic constriction, TAC), and total non-cardiomyocytes from human adult hearts. Then, in order to determine the origin of CD34+ cell that plays a role in myocardial fibrosis, bone marrow transplantation model was performed. Furthermore, t

SUBMITTER: Du L 

PROVIDER: S-EPMC9942332 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature